SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-195484
Filing Date
2024-08-07
Accepted
2024-08-07 09:21:29
Documents
20
Period of Report
2024-08-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d857014d8k.htm   iXBRL 8-K 49095
2 EX-2.1 d857014dex21.htm EX-2.1 449228
3 EX-10.1 d857014dex101.htm EX-10.1 14734
4 EX-10.2 d857014dex102.htm EX-10.2 14681
5 EX-10.3 d857014dex103.htm EX-10.3 14872
6 EX-10.4 d857014dex104.htm EX-10.4 14470
7 EX-99.1 d857014dex991.htm EX-99.1 29683
11 GRAPHIC g857014snap1.jpg GRAPHIC 4338
  Complete submission text file 0001193125-24-195484.txt   865445

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA gthx-20240806.xsd EX-101.SCH 2870
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gthx-20240806_lab.xml EX-101.LAB 17993
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gthx-20240806_pre.xml EX-101.PRE 11274
22 EXTRACTED XBRL INSTANCE DOCUMENT d857014d8k_htm.xml XML 3654
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38096 | Film No.: 241181949
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)